| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 1.9 - Pollen Allergy | 2014 | Czech Republic | IgE | 826 | 69.600 | 20140606, Panzner P
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2014 | Spain | IgE | 103 | 96.400 | 20141003, Beitia JM
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Germany | IgE | 101 | 92.080 | 20140306, Darsow U
| | 1.11 - Esophagitis, Diagnosed | 2014 | Spain | IgE | 67 | 40.300 | 20140625, Armentia A
| | 5.2.5 - Source Exposed, Children (Symptoms, IgE) | 2014 | Spain | IgE | 55 | 95.550 | 20140618, Cases B
| | 1.1 - Asymptomatic | 2014 | Spain | IgE | 50 | 2.000 | 20140625, Armentia A
| | 1.9 - Pollen Allergy | 2014 | Spain | IgE | 50 | 72.000 | 20140625, Armentia A
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Sweden | IgE | 37 | 46.000 | 20140127, Konradsen JR
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Sweden | IgE | 28 | 57.000 | 20140127, Konradsen JR
| | 1.4 - Respiratory Symptoms, Diagnosed | 2014 | Italy | IgE | 21 | 95.200 | 20141114, Costa C
| | 1.4 - Respiratory Symptoms, Diagnosed | 2013 | Spain | IgE | 187 | 46.000 | 20131016, Feliu A
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 34.290 | 20130111, Ott H
| | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 48.700 | 20131020, van Rhijn BD
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 49 | 67.000 | 20131014, Bokanovic D
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 49 | 98.000 | 20131014, Bokanovic D
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 49 | 100.000 | 20131014, Bokanovic D
| | 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 68.570 | 20130605, Simon D
| | 4.1.3 - Heterologous Source Sensitized (SPT) | 2013 | Italy | IgE | 18 | 94.440 | 20131031, Bonura A
| | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 7.280 | 20120528, Patelis A
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2012 | Spain | IgE | 233 | 29.500 | 20120726, Flores E
| | 1.4 - Respiratory Symptoms, Diagnosed | 2012 | France | IgE | 129 | 43.400 | 20121204, Caimmi D
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 65.660 | 20110223, De Knop KJ
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 40.630 | 20120528, Patelis A
| | 5.2.5 - Source Exposed, Children (Symptoms, IgE) | 2012 | Czech Republic | IgE | 82 | 90.200 | 20120424, Sekerkova A
| | 4.1.8 - Heterologous Source Sensitized (SPT, IgE) | 2012 | Spain | IgE | 68 | 52.900 | 20120726, Pedrosa M
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2012 | Spain | IgE | 55 | 54.500 | 20120726, Pedrosa M
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Austria | IgE | 54 | 57.400 | 20120310, Twaroch TE
| | 5.2.4 - Source Exposed, Adults (Symptoms, IgE) | 2012 | Czech Republic | IgE | 48 | 93.800 | 20120424, Sekerkova A
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 11.110 | 20110223, De Knop KJ
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Italy | IgE | 26 | 61.500 | 20120310, Twaroch TE
| | 1.4 - Respiratory Symptoms, Diagnosed | 2011 | Spain | IgE | 68 | 80.900 | 20110509, Rodriguez D
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2011 | Spain | IgE | 43 | 79.100 | 20110713, Cabrera-Freitag P
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Italy | IgE | 16408 | 37.940 | 20100301, Scala E
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 20.930 | 20101214, Gadisseur R
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 81.080 | 20090826, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Austria | IgE | 32 | 25.000 | 20090211, Constantin C
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 7.690 | 20091121, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Austria | IgE | 22 | 45.500 | 20090211, Constantin C
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 40.910 | 20091121, Ebo DG
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 95.000 | 20091121, Ebo DG
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 65.000 | 20091005, Ott H
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2009 | Austria | IgE | 17 | 94.000 | 20090211, Constantin C
| | 1.4 - Respiratory Symptoms, Diagnosed | 2008 | Spain | IgE | 786 | 54.960 | 20081010, Barber D
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2008 | Austria | IgE | 82 | 84.100 | 20080314, Westritschnig K
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2008 | Austria | SPT | 82 | 92.680 | 20080314, Westritschnig K
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2006 | Germany | IgE (IB) | 70 | 97.100 | 20060602, Petersen A
| | 1.4 - Respiratory Symptoms, Diagnosed | 2005 | Germany | IgE | 132 | 30.300 | | | 1.5 - Atopic Dermatitis, Diagnosed | 2005 | Germany | IgE | 113 | 21.200 | | | 3.2.1 - Source Sensitized (IgE) | 2005 | Finland | IgE | 57 | 68.000 | | | 1.5 - Atopic Dermatitis, Diagnosed | 2005 | Austria | IgE | 12 | 83.300 | | | 3.2.1 - Source Sensitized (IgE) | 2005 | Russian Federation | IgE | 12 | 42.000 | | | 1.4 - Respiratory Symptoms, Diagnosed | 2005 | Austria | IgE | 11 | 90.900 | | | 3.1.1 - Source Sensitized (SPT) | 2003 | Italy | IgE | 904 | 66.800 | | | 3.1.1 - Source Sensitized (SPT) | 2003 | Italy | IgE | 749 | 82.700 | | | 3.2.1 - Source Sensitized (IgE) | 2003 | Austria | IgE | 25 | 96.000 | | | 3.2.1 - Source Sensitized (IgE) | 2003 | Zimbabwe | IgE | 25 | 80.000 | | | 3.1.4 - Source Sensitized (SPT, IgE) | 2001 | Italy | IgE | 77 | 93.500 | | | 3.2.1 - Source Sensitized (IgE) | 2000 | Not Defined | IgE | 306 | 95.800 | | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2000 | Italy | IgE | 276 | 92.000 | | | 3.2.1 - Source Sensitized (IgE) | 1998 | Netherlands | IgE | 154 | 74.000 | | | 5.2.1 - Source Exposed (Symptoms, SPT) | 1996 | France | IgE | 38 | 95.000 | | | 5.2.1 - Source Exposed (Symptoms, SPT) | 1996 | Sweden | IgE | 35 | 86.000 | | | 5.2.1 - Source Exposed (Symptoms, SPT) | 1996 | Austria | IgE | 29 | 100.000 | | | 5.2.1 - Source Exposed (Symptoms, SPT) | 1996 | Denmark | IgE | 26 | 96.000 | | | 5.2.1 - Source Exposed (Symptoms, SPT) | 1996 | Japan | IgE | 20 | 65.000 | | | 5.2.1 - Source Exposed (Symptoms, SPT) | 1996 | Switzerland | IgE | 20 | 70.000 | | | 5.2.1 - Source Exposed (Symptoms, SPT) | 1996 | Canada | IgE | 15 | 93.000 | | | 5.3.1 - Source Exposed (Symptoms, IgE) | 1994 | Austria | IgE | 30 | 93.000 | |
|
Loading...
Phl p 1
